SPOT ON
Amount of refund according to the AMNOG (Pharmaceutical Market Restructuring Act) – Higher Social Court questions calculation and cost effectiveness
FOURIER study with evolocumab (REPATHA) – 2 million € per prevented event
THERAPY FROM A CRITICAL VIEWPOINT
Rivaroxaban for extended prophylaxis after thromboembolism?
Are antibiotics unnecessary in uncomplicated diverticulitis?
Bicalutamide (CASODEX 150 mg, generics) in PSA-recurrent prostate cancer after prostatectomy
CURRENT ADR NETWORK REPORT
Anisocoria with escitalopram (CIPRALEX, generics) free article
IN BRIEF
Dabigatran (PRADAXA) versus warfarin (COUMADIN) for ablation in atrial fibrillation
PRAC recommends suspension of marketing authorisations of four MRI contrast agents
Finally – Servier ceases distribution of strontium ranelate (PROTELOS)
FASTJECT lots recalled
e a-t ON THE INTERNET
France: 3rd and 4th generation contraceptives less and less prescribed